Sign-up for our newsletter

Phenotype Assays

Welcome to the DiaComp Phenotype Assay search page. Select a Phenotype Assay Group to limit search results to a specific type of assay. You may also specify a name and / or abbreviation to search for. To list assays specific only to DiaComp check the box next to DiaComp specific.

Click here to filter search results...

Options:   View   Drag a column header and drop it here to group by that column Name Abbreviation Units Range Protocol Options 2-deoxyglucose AUC None   0 to ∞ None absolute neutrophil count ANC   0 to ∞ None acceleration rate of early transmitral filling wave MV acc (m/s2) -∞ to ∞ Echocardiography: Mouse acetoacetate oxidation ACT OX (µMol/min/g) -∞ to ∞ None adenosine diphosphate adp   -∞ to ∞ None adenosine monophosphate AMP   -∞ to ∞ None adenosine triphosphate ATP   -∞ to ∞ None adiponectin None (mg/dL) -∞ to ∞ None Age None (w) 0 to 1092 None alanine None   0 to ∞ None alanine amino transferase ALT (U/L) 0 to ∞ None alanine aminotransferase ALT (U/L) 0 to ∞ None Alanine transaminase, blood None   0 to ∞ None albumin None (g/dL) -∞ to ∞ None albumin to creatinine ratio ACR (mg/g) 0 to 10000 None albumin, blood None   0 to ∞ None alkaline phosphatase ALP (U/L) 0 to ∞ None alkaline phosphatase, blood None   0 to ∞ None alpha ketoglutarate glutamate exchange rate Vx (µMol/min/g) -∞ to ∞ None amino acids, branched-chain None   0 to ∞ None amino acids, essential None   0 to ∞ None amino acids, gluconeogenic None (U/L) -∞ to ∞ None amino acids, glyconeogenic glyconeogenic AA   0 to ∞ None amino acids, nonessential None   0 to ∞ None AMPK Activity AMPK   -∞ to ∞ Cardiac AMPK Assay antibody None   -∞ to ∞ None antigen None   -∞ to ∞ None aortic arch (cross section) lesion area None (mm²) 0 to ∞ Quantification of atherosclerosis at the aortic sinus Aortic Atherosclerosis Morphometry - Intimal Area AAM-IA (mm²) -∞ to ∞ Atherosclerotic Morphometry in Pigs Aortic Atherosclerosis Morphometry - Intimal Area as % Medial Area AAM-IAMA (%) 0 to 100 Atherosclerotic Morphometry in Pigs Aortic Atherosclerosis Morphometry - Medial Area AAM-MA (mm²) -∞ to ∞ Atherosclerotic Morphometry in Pigs aortic flow 00 minutes AF t00 (ml/min) 0 to ∞ Phenotypic Characterization of the Working Heart aortic flow 20 minutes AF t20 (ml/min) 0 to ∞ Phenotypic Characterization of the Working Heart aortic flow 40 minutes AF t40 (ml/min) 0 to ∞ Phenotypic Characterization of the Working Heart aortic flow 60 minutes AF t60 (ml/min) 0 to ∞ Phenotypic Characterization of the Working Heart aortic lesion complexity index LCI   -∞ to ∞ None aortic pressure, mean None (mmHg) -∞ to ∞ None aortic sinus (cross section) lesion area None (μm) 0 to ∞ Quantification of atherosclerosis at the aortic sinus aortic surface area section A AorticAreaSAA (mm²) 0 to ∞ Quantification of atherosclerosis at the aortic sinus aortic surface area section B AorticAreaSAB (mm²) 0 to ∞ Quantification of atherosclerosis at the aortic sinus aortic surface area section C AorticAreaSAC (mm²) 0 to ∞ Quantification of atherosclerosis at the aortic sinus apolipoprotein A None (mg/dL) -∞ to ∞ None apolipoprotein B None (mg/dL) -∞ to ∞ None apolipoprotein C3 ApoC3 (mg/dL) 0 to 800 None Arteriolar Hyalinosis Arteriolar Hyalinosis   -∞ to ∞ None aspartate None   0 to ∞ None aspartate amino transferase AST (U/L) 0 to 1000 None aspartate aminotransferase AST (U/L) 0 to ∞ None Assay Respiratory Control RC   -∞ to ∞ None average aortic leaflet A lesion AorticLesA (mm²) 0 to ∞ Quantification of atherosclerosis at the aortic sinus average aortic leaflet B lesion AorticLesB (mm²) 0 to ∞ Quantification of atherosclerosis at the aortic sinus average aortic leaflet C lesion AorticLesC (mm²) 0 to ∞ Quantification of atherosclerosis at the aortic sinus average aortic lesion area AALA (µm²) 0 to ∞ None average clamp glucose None (mg/dL) -∞ to ∞ None average glucose infusion rate None (mg/kg/min) -∞ to ∞ None Basal Rate of Mitochondrial Respiration in the absence of added substrate State 2 (nmol O2.min-1.mgdw-1) -∞ to ∞ Evaluation of Mitochondrial Function basement membrane thickening BMT   0 to ∞ None beta-hydroxybutyrate None (µmol/l) -∞ to ∞ None bicarbonate None (mEq/L) -∞ to ∞ None bilirubin None (mg/dL) -∞ to ∞ None bilirubin, direct None (mg/dL) -∞ to ∞ None bilirubin, Total total bilirubin (mg/dL) 0 to ∞ None Bladder capacity bladder capacity (ml) 0 to ∞ None Bladder capacity - explant Bladder capacity-e (ml) 0 to ∞ None Bladder capacity - implant Bladder capacity-i (ml) 0 to ∞ None Bladder compliance - explant B compliance-e (mL/cm H2O) 0 to ∞ None Bladder compliance - implant B compliance-i (mL/cm H2O) 0 to 250 None Bladder pressure, capacity - explant B press capacity-e (cm H2O) 0 to 250 None Bladder pressure, capacity - implant B press capacity-i (cm H2O) 0 to 250 None Bladder pressure, empty - explant B pressure empty-e (cm H2O) 0 to 250 None Bladder pressure, empty - implant B pressure empty-i (cm H2O) 0 to 250 None Bladder weight Bladder weight (mg) -∞ to ∞ None Bladder weight/body weight Bladder weight/body (mg/g) -∞ to ∞ None blood pressure, mean arterial None (mmHg) -∞ to ∞ None blood pressure: developed DVP (mmHg) 0 to ∞ Phenotypic Characterization of the Working Heart blood pressure: developed 00 minutes DVP t00 (mmHg) 0 to ∞ Phenotypic Characterization of the Working Heart blood pressure: developed 20 minutes DVP t20 (mmHg) 0 to ∞ Phenotypic Characterization of the Working Heart blood pressure: developed 40 minutes DVP t40 (mmHg) 0 to ∞ Phenotypic Characterization of the Working Heart blood pressure: developed 60 minutes DVP t60 (mmHg) 0 to ∞ Phenotypic Characterization of the Working Heart blood pressure: diastole dBP (mmHg) 0 to ∞ Phenotypic Characterization of the Working Heart blood pressure: diastole 00 minutes dBP t00 (mmHg) 0 to ∞ Phenotypic Characterization of the Working Heart blood pressure: diastole 20 minutes dBP t20 (mmHg) 0 to ∞ Phenotypic Characterization of the Working Heart blood pressure: diastole 40 minutes dBP t40 (mmHg) 0 to ∞ Phenotypic Characterization of the Working Heart blood pressure: diastole 60 minutes dBP t60 (mmHg) 0 to ∞ Phenotypic Characterization of the Working Heart blood pressure: mean arterial aBP (mmHg) -∞ to ∞ None blood pressure: systole sBP (mmHg) 0 to ∞ Phenotypic Characterization of the Working Heart blood pressure: systole 00 minutes sBP t00 (mmHg) 0 to ∞ Phenotypic Characterization of the Working Heart blood pressure: systole 20 minutes sBP t20 (mmHg) 0 to ∞ Phenotypic Characterization of the Working Heart blood pressure: systole 40 minutes sBP t40 (mmHg) 0 to ∞ Phenotypic Characterization of the Working Heart blood pressure: systole 60 minutes sBP t60 (mmHg) 0 to ∞ Phenotypic Characterization of the Working Heart body length A/N (rodent) A/N (rodent) (cm) 0 to ∞ None body mass W rodent (g) 0 to 100 None body surface area BSA (m²) 0 to 4 None body water, absolute amount None (g) -∞ to ∞ None body water, free free water (g) -∞ to ∞ None body weight (human) W (human) (kg) 0 to 200 None body weight (pig) W pig (kg) 0 to ∞ None bone area bone area (cm²) -∞ to ∞ None bone mineral content BMC (g) -∞ to ∞ None bone mineral density BMD (g/cm²) -∞ to ∞ None brain mass brain wt (g) 0 to 3 None brain weight (rodent) brain weight (rodent (g) 0 to ∞ None BUN/Creatinine Ratio Bun/Creatinine (ratio) 0 to ∞ None calcium None (mg/dL) -∞ to ∞ None calcium, blood None (mg/dL) 0 to ∞ None carbon dioxide production VCO2 (CO2/kg/hr) -∞ to ∞ None carbon dioxide, blood None   0 to ∞ None cardiac efficiency Ceff (%) 0 to 100 Phenotypic Characterization of the Working Heart cardiac efficiency 00 minutes Ceff t00 (%) 0 to 100 Phenotypic Characterization of the Working Heart cardiac efficiency 20 minutes Ceff t20 (%) 0 to 100 Phenotypic Characterization of the Working Heart cardiac efficiency 40 minutes Ceff t40 (%) 0 to 100 Phenotypic Characterization of the Working Heart cardiac efficiency 60 minutes Ceff t60 (%) 0 to 100 Phenotypic Characterization of the Working Heart cardiac ejection fraction None (%) 0 to 100 None cardiac function, intraventricular pressure: diastole None (mmHg) -∞ to ∞ None cardiac function, intraventricular pressure: end diastole None (mmHg) -∞ to ∞ None cardiac function, intraventricular pressure: systole None (mmHg) -∞ to ∞ None cardiac output None   0 to ∞ None cardiac power 00 minutes CP t00 (mW/g) 0 to ∞ Phenotypic Characterization of the Working Heart cardiac power 20 minutes CP t20 (mW/g) 0 to ∞ Phenotypic Characterization of the Working Heart cardiac power 40 minutes CP t40 (mW/g) 0 to ∞ Phenotypic Characterization of the Working Heart cardiac power 60 minutes CP t60 (mW/g) 0 to ∞ Phenotypic Characterization of the Working Heart cardiac venous return None (ml/min) -∞ to ∞ None chloride concentration None (U/kg) -∞ to ∞ None chloride, blood None   0 to ∞ None cholesterol None (mg/dL) -∞ to ∞ None cholesterol concentration in low density lipoproteins None (mg/dL) -∞ to ∞ None cholesterol concentration in very low density lipoproteins None (mg/dL) -∞ to ∞ None cholesterol remaining in intestinal lumen None (%) -∞ to ∞ None cholesterol remaining in intestinal lymph None (%) -∞ to ∞ None cholesterol remaining in intestinal mucosa None (%) -∞ to ∞ None Cholesterol transported in lymph Cholesterol in lymph (%) -∞ to ∞ None cholesterol, CM, plasma CM-cholesterol (mg/dL) 0 to 10000 None cholesterol, fractional clearance rate CHOL FCR (min) -∞ to ∞ None cholesterol, HDL None (%) -∞ to ∞ None cholesterol, HDL (COBAS) HDL-COBAS (mg/dL) 0 to ∞ None cholesterol, HDL (UC) HDL-UC (mg/dL) 0 to ∞ Ultracentrifugal separation of VLDL, LDL and HDL Cholesterol, Hepatic Uptake Hepatic CHOL uptake (%) -∞ to ∞ None cholesterol, splenic uptake Splenic CHOL uptake (%) -∞ to ∞ None cholesterol, total TC (mg/dL) 0 to ∞ Lipid Profiles in Mice cholesteryl ester fatty acids None (%) 0 to 100 None cholesteryl ester in chylomicrons CE-CM (% wt/wt) -∞ to ∞ None cholesteryl esters None (µg/mg) 0 to ∞ None chylomicrons None (%) -∞ to ∞ None Circumflex Coronary Artery Atherosclerosis Morphometry - Intimal Area CIRCAM-IA (mm²) 0 to ∞ Atherosclerotic Morphometry in Pigs Circumflex Coronary Artery Atherosclerosis Morphometry - Intimal Area as % Medial Area CIRCAM-IAMA (%) 0 to 100 Atherosclerotic Morphometry in Pigs Circumflex Coronary Artery Atherosclerosis Morphometry - Medial Area CIRCAM-MA (mm²) -∞ to ∞ Atherosclerotic Morphometry in Pigs Circumflex Coronary Artery Atherosclerosis Morphometry - Percent Stenosis CIRCAM-%S (%) 0 to 100 Atherosclerotic Morphometry in Pigs citrate flux rate None (µMol/min/g) -∞ to ∞ None citrate synthase flux rate citrate synthase FR   -∞ to ∞ None cleaved caspase-3 detection None   0 to ∞ None CoA ester, C16:0 None (nmol/g-tissue) -∞ to ∞ None CoA ester, C16:1 None (nmol/g-tissue) -∞ to ∞ None CoA ester, C18:0 None (nmol/g-tissue) -∞ to ∞ None CoA ester, C18:1 None (nmol/g-tissue) -∞ to ∞ None CoA ester, C18:2 None (nmol/g-tissue) -∞ to ∞ None CoA ester, C18:3 None (nmol/g-tissue) -∞ to ∞ None CoA esters, long-chain None (nmole) -∞ to ∞ None complex lesions/total lesion ratio C/total lesion   -∞ to ∞ Quantification of atherosclerosis at the aortic sinus Complexes None (bpm) 0 to ∞ None compliance compliance   -∞ to ∞ None coronary flow CF (ml/min) 0 to ∞ Phenotypic Characterization of the Working Heart coronary flow 00 minutes CF t00 (ml/min) 0 to ∞ Phenotypic Characterization of the Working Heart coronary flow 20 minutes CF t20 (ml/min) 0 to ∞ Phenotypic Characterization of the Working Heart coronary flow 40 minutes CF t40 (ml/min) 0 to ∞ Phenotypic Characterization of the Working Heart coronary flow 60 minutes CF t60 (ml/min) 0 to ∞ Phenotypic Characterization of the Working Heart coronary flow/heart weight CF/HW (ml/min/g) 0 to ∞ Phenotypic Characterization of the Working Heart corticosterone None (ng/ml) -∞ to ∞ None corticosterone, plasma, arterial None (µg/mg) 0 to ∞ None creatinine, blood blood creatinine (mg/dL) 0 to ∞ None creatinine, plasma plasma cre (mg/dL) 0 to ∞ None creatinine, serum SCR (mg/dL) 0 to ∞ None creatinine, urine (Exocell Picric Acid method) ucreat (mg/dL) 0 to ∞ None creatinine, urine (spot) ucreatinine-spot (mg/dL) -∞ to ∞ None creatinine, urine, 24h (HPLC) UCreat-HPLC (mg/dL) -∞ to ∞ None diacyglycerols None (µg/mg) 0 to ∞ None diacylglycerol fatty acids None (%) 0 to 100 None DR D   -∞ to ∞ None dry heart weight DHW (g) 0 to ∞ Phenotypic Characterization of the Working Heart duration of recording None (min) 0 to ∞ None early transmitral flow velocity E (m/s) 0 to ∞ Echocardiography: Mouse EKG-Beginning to end of QRS complex EKG-QRS (msec) -∞ to ∞ None EKG-Interval between R-waves EKG-RR (msec) -∞ to ∞ None EKG-Interval between the peak of P-wave to Q-wave EKG-PQ (msec) -∞ to ∞ None EKG-Interval between the peak of P-wave to R-wave EKG-PR (msec) -∞ to ∞ None EKG-Interval between the peak of Q-wave to end of T-wave EKG-QT (msec) -∞ to ∞ None EKG-Interval between the peak of S-wave to end of T-wave EKG-ST (msec) -∞ to ∞ None EKG-Rate-corrected QT EKG-QTc (msec) -∞ to ∞ None en face abdominal aorta lesion area EFAbALA (mm²) -∞ to ∞ En face preparation and quantification of aortic surface area covered by atherosclerotic lesions en face abdominal aorta lesion area % EFAbALA% (%) 0 to 100 En face preparation and quantification of aortic surface area covered by atherosclerotic lesions En Face Abdominal Aorta Lesion Area (Pig) EFAbALA (Pig) (cm²) -∞ to ∞ Atherosclerotic Morphometry in Pigs En Face Abdominal Aorta Lesion Percent (Pig) EFAbAL% (Pig) (%) 0 to 100 Atherosclerotic Morphometry in Pigs en face abdominal aorta total area EFAbATA (mm²) -∞ to ∞ En face preparation and quantification of aortic surface area covered by atherosclerotic lesions En Face Abdominal Aorta Total Area (Pig) EFAbATA (Pig) (cm²) -∞ to ∞ Atherosclerotic Morphometry in Pigs en face aortic arch lesion area EFAALA (mm²) -∞ to ∞ En face preparation and quantification of aortic surface area covered by atherosclerotic lesions en face aortic arch lesion area % EFAALA% (%) 0 to 100 En face preparation and quantification of aortic surface area covered by atherosclerotic lesions en face aortic arch total area EFAATA (mm²) -∞ to ∞ En face preparation and quantification of aortic surface area covered by atherosclerotic lesions en face thoracic aorta lesion area EFTALA (mm²) -∞ to ∞ En face preparation and quantification of aortic surface area covered by atherosclerotic lesions en face thoracic aorta lesion area % EFTALA% (%) 0 to 100 En face preparation and quantification of aortic surface area covered by atherosclerotic lesions en face thoracic aorta total area EFTATA (mm²) -∞ to ∞ En face preparation and quantification of aortic surface area covered by atherosclerotic lesions endothelial cell density Mean_NV_ENDO (num/µm³) 0 to ∞ None endothelial/mesangial cell number Mean_N_EN_MES (num/glomerulus) 0 to ∞ None endurance time None (min) 0 to ∞ None energy expenditure None (kcal/hr/kg) -∞ to ∞ None energy expenditure, 30 min exercise None   0 to ∞ None energy expenditure, basal None   0 to ∞ None energy expenditure, exhaustion None   0 to ∞ None energy expenditure, maximum None   0 to ∞ None energy intake (24 hr) None (Kcal/day) -∞ to ∞ None epinephrine, plasma, arterial None   0 to ∞ None euglycemic clamp None   0 to ∞ Glucose exploratory activity None   0 to ∞ None fasting glucose None (mg/dL) 0 to ∞ None fasting insulin None   0 to ∞ None fat absorbtion, dietary None (%) -∞ to ∞ None fat body mass None (g) 0 to ∞ None fat tissue mass None (g) -∞ to ∞ None fat tissue, % % body fat (%) 0 to 100 None fat tissue, brown BAT wt (g) 0 to 7 None fat tissue, epidymal epidymal fat wt (g) 0 to 7 None fat tissue, periovarian PFD wt (g) 0 to 7 None fat tissue, retroperitoneal retroperitoneal fat (g) 0 to 7 None fat tissue, subcutaneous subcutaneous fat wt (g) 0 to 7 None fatty streaks/total lesion ratio FS/total lesion   0 to ∞ Quantification of atherosclerosis at the aortic sinus Fecal Output None (g) -∞ to ∞ None fenestrated endothelium PCT_Fenestrated_Endo (%) 0 to 100 None fenestrated endothelium opposite denuded basement membrane PCT_Fen_endo_for_DGB (%) 0 to 100 None filtration slit frequency Mean_FSF (num/mm) 0 to ∞ None foot process width Mean_FPW (nm) 0 to ∞ None fractional mesangial cell volume/glomerulus Vv(MC/glom)   0 to 1 None fractional mesangial matrix volume/glomerulus Vv(MM/glom)   0 to 1 None fractional mesangial volume/glomerulus Vv(Mes/glom)   0 to 1 None fractional shortening None   0 to ∞ Echocardiography: Mouse Frequently sampled intravenous glucose tolerance test - Glucose Conc. FSIGT-Glucose (mg/dL) -∞ to ∞ Frequently sampled intravenous glucose tolerance test Frequently sampled intravenous glucose tolerance test - Insulin Conc. FSIGT-Insulin (mg/dL) -∞ to ∞ Frequently sampled intravenous glucose tolerance test GABA and glutamate None   0 to ∞ None GFR creatinine clearance (HPLC) GFR HPLC   0 to ∞ Creatinine Clearance by HPLC GFR inulin clearance (FITC-inulin IV bolus injection) GFR FITC (µl/min) 0 to 1500 Determination of Glomerular Filtration Rate in Conscious Mice using FITC-inulin GFR inulin clearance (osmotic mini-pump) GFR Pump   0 to ∞ Determination of Glomerular Filtration Rate in Conscious Mice using FITC-inulin glomerular basement membrane - denuded PCT_Denuded_GBM (%) 0 to 100 None glomerular basement membrane thickness GBM Width (μm) 0 to ∞ None glomerular filtration rate GFR (ml/min) -∞ to ∞ None glomerular volume Glom Vol (µm³) 0 to ∞ Podocyte Count and Density Analysis glomerular volume per podocyte GV/P (µm³) 0 to ∞ Podocyte Count and Density Analysis glomeruli globally sclerosed PCT_Global_Sclerosis (%) 0 to 100 None glomeruli number Number_of_LM_Glomeru   0 to ∞ None glucagon None (pg/ml) -∞ to ∞ None glucagon, plasma, arterial None   0 to ∞ None gluconeogenesis rate None (mg/kg/min) 0 to ∞ None glucose appearance, endogenous None   -∞ to ∞ None glucose infusion rate None   -∞ to ∞ None glucose infusion rates None (mg/kg/min) 0 to ∞ None glucose metabolic index, brain None   0 to ∞ None glucose metabolic index, diaphragm None   0 to ∞ None glucose metabolic index, gastrocnemius None   0 to ∞ None glucose metabolic index, heart None   -∞ to ∞ None glucose metabolic index, soleus None   0 to ∞ None glucose metabolic index, superficial vastus lateralis None   0 to ∞ None glucose oxidation None (µMol/min/g) -∞ to ∞ None glucose oxidation 00-20 minutes Glox t00-t20 (nmol/min/g) 0 to ∞ Phenotypic Characterization of the Working Heart glucose oxidation 20-40 minutes Glox t20-t40 (nmol/min/g) 0 to ∞ Phenotypic Characterization of the Working Heart glucose oxidation 40-60 minutes Glox t40-t60 (nmol/min/g) 0 to ∞ Phenotypic Characterization of the Working Heart glucose production None (µMol/min/g) -∞ to ∞ None glucose rate of appearance, endogenous endo RA (mg/kg/min) -∞ to ∞ None glucose rate of disappearance None   -∞ to ∞ None glucose synthesis None (nmol/min/g) -∞ to ∞ None glucose turnover, whole body None (mg/kg/min) -∞ to ∞ None glucose uptake None (nmol/min/g) -∞ to ∞ Glucose uptake in isolated cardiomyocytes. glucose, arterial None (mg/dL) -∞ to ∞ None glucose, basal None (mg/dL) -∞ to ∞ None glucose, blood blood glucose (mg/dL) 0 to ∞ None glucose, blood, arterial None   -∞ to ∞ None glucose, clamp average None (mg/dL) -∞ to ∞ None glucose, plasma plasma glucose (mg/dL) 0 to ∞ None glucose, rate of disappearance Rd (mg/kg/min) -∞ to ∞ None glucose, urine None (mg/dL) 0 to ∞ None glutamate None   0 to ∞ None glutamine None   0 to ∞ None glutamine dehydrogenase GLDH (U/L) 0 to ∞ None glutamine rate of appearance in blood None   0 to ∞ None glutamine rate of disappearance in blood None   0 to ∞ None glutamine, blood, arterial None   0 to ∞ None glycerol None (µMol/min/g) -∞ to ∞ None glycerol flux rate glycerol FR   -∞ to ∞ None glycerol fraction glycerol fraction   -∞ to ∞ None glycerol, plasma None (mg/dL) 0 to 500 None glycine None   0 to ∞ None glycogen flux rate glycogen FR   -∞ to ∞ None glycogen fraction glycogen fraction   -∞ to ∞ None glycogen synthesis None (nmol/min/g) -∞ to ∞ None glycogen, gastrocnemius None   -∞ to ∞ None glycogen, heart None   -∞ to ∞ None glycogen, liver None   0 to ∞ None glycogen, muscle None   -∞ to ∞ None glycogen, superficial vastus lateralis None   0 to ∞ None glycogen/lipid synthesis, whole body None (mg/kg/min) -∞ to ∞ None glycogenolytic rate None (mg/kg/min) 0 to ∞ None glycolysis None (nmol/min/g) -∞ to ∞ None glycolysis 00-20 minutes Glyc t00-t20 (nmol/min/g) 0 to ∞ Phenotypic Characterization of the Working Heart glycolysis 20-40 minutes Glyc t20-t40 (nmol/min/g) 0 to ∞ Phenotypic Characterization of the Working Heart glycolysis 40-60 minutes Glyc t40-t60 (nmol/min/g) 0 to ∞ Phenotypic Characterization of the Working Heart glycolysis, whole body None (mg/kg/min) -∞ to ∞ None glycosylated hemoglobin GHb (%) 0 to 30 None HbA1c HbA1c (%) 0 to 100 None heart mass cardiac muscle weigh (g) 0 to 3 None heart rate HR (bpm) 0 to ∞ Phenotypic Characterization of the Working Heart heart weight:tibia length ratio Heart:TL (g/mm) 0 to ∞ Morphometry: Mouse heart:body weight ratio Heart:BW   0 to ∞ Morphometry: Mouse heat HEAT (Kcal/hr) -∞ to ∞ None Height (human) Height (cm) 0 to 220 None hematocrit Hct   0 to ∞ None hematocrit, arterial None (%) -∞ to ∞ None Hematocrit, HCT None (%) 0 to 100 None hemoglobin hemoglobin (g/dL) 0 to ∞ None hepatic glucose production, basal None (mg/kg/min) -∞ to ∞ None Hepatic Glucose Production, clamp None (mg/kg/min) -∞ to ∞ None Histidine None   0 to ∞ None IL-6 concentration (ELISA) IL-6   0 to ∞ None in vivo cardiac contractile performance None   0 to ∞ None Insulin 16.8 mM glucose None   0 to ∞ None Insulin 16.8 mM glucose + IBMX None   0 to ∞ None Insulin 5.6 mM glucose None   0 to ∞ None Insulin 5.6 mM glucose + tollbutamide None   0 to ∞ None insulin dose None (µMol/min/g) -∞ to ∞ None Insulin Sensitivity SI (mu/L/min) -∞ to ∞ Frequently sampled intravenous glucose tolerance test insulin, arterial None (mg/dL) -∞ to ∞ None insulin, basal None (ng/ml) 0 to ∞ None insulin, blood None (ng/dl) 0 to ∞ None insulin, clamp None (ng/ml) 0 to ∞ None insulin, experimental None   -∞ to ∞ None insulin, plasma None (pg/ml) 5 to 500000 None insulin, plasma, arterial None   0 to ∞ None insulin, serum S Insulin   0 to ∞ None intercontraction interval intercontraction int (sec) -∞ to ∞ None interventricular septal diameter diastole IVSd (mm) 0 to ∞ Echocardiography: Mouse interventricular septal diameter systole IVSs (cm) 0 to ∞ Echocardiography: Mouse intraepidermal nerve fibers IENF (num/mm) 1 to 50 Prepare Plantar Footskin for Morphometry intraperitoneal glucose tolerance test: 000min (baseline) IPGTT t000 (mg/dL) 0 to ∞ Intraperitoneal Glucose Tolerance Testing (IPGTT) intraperitoneal glucose tolerance test: 005min post-injection IPGTT t005 (mg/dL) 0 to ∞ Intraperitoneal Glucose Tolerance Testing (IPGTT) intraperitoneal glucose tolerance test: 015min post-injection IPGTT t015 (mg/dL) 0 to ∞ Intraperitoneal Glucose Tolerance Testing (IPGTT) intraperitoneal glucose tolerance test: 030min post-injection IPGTT t030 (mg/dL) 0 to ∞ Intraperitoneal Glucose Tolerance Testing (IPGTT) intraperitoneal glucose tolerance test: 060min post-injection IPGTT t060 (mg/dL) 0 to ∞ Intraperitoneal Glucose Tolerance Testing (IPGTT) intraperitoneal glucose tolerance test: 120min post-injection IPGTT t120 (mg/dL) 0 to ∞ Intraperitoneal Glucose Tolerance Testing (IPGTT) intravenous glucose tolerance IVGTT   0 to ∞ None isoleucine None   0 to ∞ None ketoisocaproic, blood, arterial None   0 to ∞ None ketones, urine urine ketones   -∞ to ∞ None Kf, brain None   0 to ∞ None Kf, diaphragm None   0 to ∞ None Kf, diaphragms None   0 to ∞ None Kf, gastrocnemius None   0 to ∞ None Kf, heart None   0 to ∞ None Kf, soleus None   0 to ∞ None Kf, superficial vastus laterlis None   0 to ∞ None Kg, adipose None (ml/100g/min) 0 to ∞ None Kg, brain None (ml/100g/min) 0 to ∞ None Kg, diaphragm None (ml/100g/min) 0 to ∞ None Kg, gastrocnemius None (ml/100g/min) 0 to ∞ None Kg, heart None (ml/100g/min) 0 to ∞ None Kg, soleus None (ml/100g/min) 0 to ∞ None Kg, superficial vastus lateralis None (ml/100g/min) 0 to ∞ None Kg, vastus lateralis None (ml/100g/min) -∞ to ∞ None kidney weight:tibia length ratio Kid:TL (g/mm) 0 to ∞ Morphometry: Mouse kidney, long-axis area None (cm) 0 to ∞ None kidney, long-axis area, right right kidney LAArea (cm) 0 to ∞ None kidney, long-axis circle None (cm) 0 to ∞ None kidney, long-axis circle, right right kidney LACircl (cm) 0 to ∞ None kidney, long-axis HGT None (cm) 0 to ∞ None kidney, long-axis HGT, right right kidney LAHGT (cm) 0 to ∞ None kidney, long-axis LGT None (cm) 0 to ∞ None kidney, long-axis LGT, right right kidney LALGT (cm) 0 to ∞ None kidney, short-axis area, right right kidney SAArea (cm) 0 to ∞ None kidney, short-axis circle None (cm) 0 to ∞ None kidney, short-axis circle, right right kidney SACircl (cm) 0 to ∞ None kidney, short-axis HGT None (cm) 0 to ∞ None kidney, short-axis HGT, right right kidney SAHGT (cm) 0 to ∞ None kidney, short-axis LGT None (cm) 0 to ∞ None kidney, short-axis WDT None (cm) 0 to ∞ None kidney, short-axis WDT, right right kidney SAWDT (cm) 0 to ∞ None lactate dehydrogenase lactate dehydrogenas (U/L) 0 to ∞ None Langerhans cells LC (num/mm) -∞ to ∞ None lean body mass None (g) -∞ to ∞ None lean tissue mass None (g) -∞ to ∞ None lean tissue, % % lean mass (%) 0 to 100 None Left Anterior Descending Coronary Artery Morphometry - Intimal Area LADCAM-IA (mm²) 0 to ∞ Atherosclerotic Morphometry in Pigs Left Anterior Descending Coronary Artery Morphometry - Intimal Area as % Medial Area LADCAM-IAMA (%) 0 to 100 Atherosclerotic Morphometry in Pigs Left Anterior Descending Coronary Artery Morphometry - Medial Area LADCAM-MA (mm²) 0 to ∞ Atherosclerotic Morphometry in Pigs Left Anterior Descending Coronary Artery Morphometry - Percent Stenosis LADCAM-%S (%) 0 to 100 Atherosclerotic Morphometry in Pigs left atrial pressure None (mmHg) -∞ to ∞ None left kidney weight (mouse) L Kid Wt (g) 0 to 3 Morphometry: Mouse left ventricle anterior wall thickness, end diastolic LVAWT-end diastolic (mm) 0 to ∞ None left ventricle chamber diameter end diastolic None (mm) -∞ to ∞ None left ventricle chamber diameter end systolic None (mm) -∞ to ∞ None Left Ventricle End Diastolic Pressure LVeDP (mmHg) -∞ to ∞ Measurement of Left Ventricular Hemodynamic Parameters in Intact Mice left ventricle interior diameter end diastolic LVID-end diastolic   0 to ∞ None left ventricle interior diameter end systolic LVID-end systoloic (mm) 0 to ∞ None left ventricle internal diameter end-diastole None (cm) 0 to ∞ None left ventricle internal diameter end-systole None (cm) 0 to ∞ None left ventricle mass None (g) 0 to ∞ None left ventricle posterior wall thickness end diastolic LVPWT-end diastolic (mm) -∞ to ∞ None left ventricle posterior wall thickness end systolic LVPWT-end systolic (mm) -∞ to ∞ None left ventricle posterior wall thickness end-diastole LVPWT-end diaastole (cm) 0 to ∞ None left ventricle posterior wall thickness end-systole LVPWT-end systole (cm) 0 to ∞ None left ventricle septal wall thickness end-diastole LVSWT-end diastole (cm) 0 to ∞ None left ventricle septal wall thickness end-systole LVSWT-end systole (cm) 0 to ∞ None left ventricle septum wall thickness end diastolic LVSWT-end diastole (mm) -∞ to ∞ None left ventricle septum wall thickness end systolic LVSWT-end systolic (mm) -∞ to ∞ None left ventricular cavity size LV cavity size (mm) 0 to ∞ Echocardiography: Mouse left ventricular diameter diastolic LVDd (cm) 0 to ∞ Echocardiography: Mouse left ventricular diameter systolic LVDs (cm) 0 to ∞ Echocardiography: Mouse left ventricular ejection fraction LV ejection fraction (%) 0 to ∞ Echocardiography: Mouse left ventricular mass LV mass (mg) 0 to ∞ Echocardiography: Mouse left ventricular minute work LV Minute work (mEq/L) -∞ to ∞ None left ventricular outflow index LVOT VTI (cm) 0 to ∞ Echocardiography: Mouse left ventricular posterior wall diameter in diastole LVPWd (mm) 0 to ∞ Echocardiography: Mouse left ventricular systolic pressure LVSP (mmHg) 0 to ∞ Phenotypic Characterization of the Working Heart left ventricular wall thickness LV wall thickness   0 to ∞ Echocardiography: Mouse leptin None (ng/dl) -∞ to ∞ None leptin (RIA) Leptin   0 to ∞ None leucine None   0 to ∞ None leucine appearance reciprocal model rate None   0 to ∞ None leucine disappearance rate None   0 to ∞ None leucine, blood, arterial None   0 to ∞ None lipids, blood None (mg/dL) 0 to ∞ None lipoprotein, intermediate density None   0 to ∞ None lipoproteins, alpha None (%) -∞ to ∞ None lipoproteins, beta None (%) -∞ to ∞ None lipoproteins, LDL None   0 to ∞ None lipoproteins, pre-beta None (%) -∞ to ∞ None liver mass Liver Wt (g) 0 to 6 None liver weight:tibia length ratio Liver:TL (g/mm) 0 to ∞ Morphometry: Mouse liver:body weight ratio Liver:BW   0 to ∞ Morphometry: Mouse low-density lipoprotein cholesterol LDL (mg/dL) 0 to ∞ Ultracentrifugal separation of VLDL, LDL and HDL lymph flow lymph flow (ml/hr) -∞ to ∞ None Lysine None   0 to ∞ None magnesium None (mEq/L) -∞ to ∞ None mammary gland mass Mammary wt (g) 0 to 3 None Maximal ADP stimulated Mitochondrial Respiration Rate State 3 (nmol O2.min-1.mgdw-1) -∞ to ∞ Evaluation of Mitochondrial Function mean axonal diameter MAD (μm) 1 to 10 Preparing Nerves for Morphometry mean brachiocephalic artery lesion size None (µm²) 0 to ∞ Quantification of atherosclerosis at the aortic sinus mean cell volume MCV (fL) 0 to ∞ None mean corpuscular hemoglobin MCH (pg) 0 to ∞ None mean corpuscular hemoglobin concentration MCHC (g/dL) 0 to ∞ None mean corpuscular volume MCPV   0 to ∞ None Mean fractional interstitial area Mean_FIA (%) 0 to 100 None Mean fractional mesangial area Mean_AA_MES (%) 0 to 100 None mean platelet volume MPV   0 to ∞ None Mean surface area Mean_SV (µm²/µm³) 0 to ∞ None mean surface area per glomerulus SA_using_LM_Means (µm²) 0 to ∞ None mean void volume mean void volume (ml) -∞ to ∞ None mean void volume (24 hour) mvv (24 hour) (ml/event) -∞ to ∞ None mesangial cell density Mean_NV_MES (num/µm³) 0 to ∞ None mesangial index PAS (%PAS/glom) 0 to 100 Mesangial Index Quantification Mesangial Sclerosis Mesangial Sclerosis   -∞ to ∞ None methionine None   0 to ∞ None micturition event micturition event   -∞ to ∞ None Mitochondrial Respiration in the absence of ATP synthesis State 4 (nmol O2.min-1.mgdw-1) -∞ to ∞ Evaluation of Mitochondrial Function muscle mass, skeletal skeletal muscle weig (g) 0 to 3 None myelinated fiber number MF   1 to 10000 Preparing Nerves for Morphometry myocardial oxygen consumption MVO2 (µMol/min/g) 0 to ∞ Phenotypic Characterization of the Working Heart myocardial oxygen consumption 00 minutes MVO2 t00 (ml/min/g) 0 to ∞ Phenotypic Characterization of the Working Heart myocardial oxygen consumption 20 minutes MVO2 t20 (ml/min/g) 0 to ∞ Phenotypic Characterization of the Working Heart myocardial oxygen consumption 40 minutes MVO2 t40 (ml/min/g) 0 to ∞ Phenotypic Characterization of the Working Heart myocardial oxygen consumption 60 minutes MVO2 t60 (ml/min/g) 0 to ∞ Phenotypic Characterization of the Working Heart NEFA FFA   -∞ to ∞ None NEFA oxidation None (umol/min/g) -∞ to ∞ None NEFA oxidation, free FFA OX (µMol/min/g) -∞ to ∞ None NEFA, arterial None   0 to ∞ None NEFA, in chylomicrons FFA in CM (% wt/wt) -∞ to ∞ None NEFA, plasma None   -∞ to ∞ None NEFA, plasma, arterial apNEFA   -∞ to ∞ None NEFA, plasma, arterial, clamp None   -∞ to ∞ None NEFA, plasma, arterial, fatty acids None   -∞ to ∞ None NEFA, short-chain None (µg/mg) 0 to ∞ None negative pressure change/time -dP/dt (mmHg/sec) -∞ to ∞ Measurement of Left Ventricular Performance in Langendorff Perfused Mouse Hearts neointimal hyperplasia Neo Hyperplasia (µm²) 0 to ∞ None non-esterified free fatty acids NEFA (µmol/l) 0 to ∞ None norepinephrine, plasma, arterial None   0 to ∞ None octanoate oxidation OCT OX (µMol/min/g) -∞ to ∞ None oral glucose tolerance OGTT   0 to ∞ None osmolality None (fL) -∞ to ∞ None osmolality (Calculated) osmolality (mOsm/L) 0 to ∞ None oxygen consumption VO2 (O2/kg/hr) -∞ to ∞ None oxygen consumption (Light Period) VO2-L (O2/kg/hr) -∞ to ∞ None palmitate oxidation 00-20 minutes Pox t00-t20 (nmol/min/g) 0 to ∞ Phenotypic Characterization of the Working Heart palmitate oxidation 20-40 minutes Pox t20-t40 (nmol/min/g) 0 to ∞ Phenotypic Characterization of the Working Heart palmitate oxidation 40-60 minutes Pox t40-t60 (nmol/min/g) 0 to ∞ Phenotypic Characterization of the Working Heart Pancreatic Insulin Content PIC (ng/µg) 0.005 to 200 Pancreatic Insulin Concentration PEPCK None (µMol/min/g) -∞ to ∞ None percent basophils % baso (%) 0 to 100 None percent body fat (Pig) % body fat (Pig) (%) 0 to 100 Serum, Blood and Body Weight Measurements in Pigs percent body fat (rodent) %BF (rodent) (%) 0 to 100 None percent eosinophils % eos (%) 0 to 100 None percent lymphocytes % lymphocytes (%) 0 to 100 None percent monocytes % mono (%) 0 to 100 None percent neutrophils % neutro (%) 0 to 100 None percent of aortic surface covered by lesion %AorticLes (%) 0 to 100 Quantification of atherosclerosis at the aortic sinus phenylalanine None   0 to ∞ None phenylalanine appearance in blood rate None   0 to ∞ None phenylalanine disappearance rate None   0 to ∞ None phenylalanine, blood, arterial None   0 to ∞ None phosphate, blood None (mg/dL) 0 to ∞ None phosphate, blood, inorganic blood inorganic phos (mg/dL) 0 to ∞ None Phosphatidyl choline None (µg/mg) 0 to ∞ None phosphatidyl ethanolamine None (µg/mg) 0 to ∞ None Phosphatidyl serine None (µg/mg) 0 to ∞ None phosphoenolpyruvate None (µMol/min/g) -∞ to ∞ None Phosphoenolpyruvate carboxykinase flux rate PEPCK FR   -∞ to ∞ None phosphoenolpyruvate flux rate PEP FR   -∞ to ∞ None phosphoenolpyruvate fraction PEP fraction   -∞ to ∞ None phospholipid None (mg/dL) -∞ to ∞ None phospholipid fatty acids None (%) 0 to 100 None phospholipids, chylomicrons PL-CM (% wt/wt) -∞ to ∞ None plantar hind paw analgesia test PHPAT (sec) 0 to 35 Plantar Analgesia Test for Hind Paw and Tail plasma adiponectin concentration (RIA) pAdip   0 to ∞ None plasma free fatty acids FFA (mg/dL) 0 to ∞ None plasma hepatic lipase activity pHepLA (mu/dL) 0 to ∞ None plasma PAI-1 concentration (ELISA) pPAI-1   0 to ∞ None plasma triglycerides pTG (mg/dL) 0 to ∞ None plasma unesterified cholesterol UC (mg/dL) 0 to ∞ None platelet count PLT (10^3/mm3) 0 to ∞ None podocyte density P/GVt (num/µm³) -∞ to ∞ None podocyte number POD (num/glomerulus) 0 to ∞ Podocyte Count and Density Analysis positive pressure change/time +dP/dt (mmHg/sec) -∞ to ∞ Measurement of Left Ventricular Performance in Langendorff Perfused Mouse Hearts Post-op body weight (Rodent) PostOPW rodent (g) 0 to 200 None potassium, blood None   0 to ∞ None Pre-op body weight (Rodent) PreOPW rodent (g) 0 to 200 None pressure change/time maximum dP/dt min (mmHg/sec) -∞ to ∞ Measurement of Left Ventricular Performance in Langendorff Perfused Mouse Hearts pressure change/time minimum dP/dt max (mmHg/sec) -∞ to ∞ Measurement of Left Ventricular Performance in Langendorff Perfused Mouse Hearts pressure development, maximal rate None   -∞ to ∞ None proline None (µmol/l) -∞ to ∞ None protein None (g/dL) -∞ to ∞ None protein, chylomicrons Protein-CM (% wt/wt) -∞ to ∞ None protein, total blood None   0 to ∞ None pulse None (bpm) 0 to ∞ None pyruvate cycling flux rate PC FR   -∞ to ∞ None pyruvate oxidation PYRV OX (ng/ml) -∞ to ∞ None Rat Pressure Product (Developed Pressure time HR) RPP (mmHg/min) -∞ to ∞ None red blood cell count RBC (10^3/mm3) 0 to ∞ None relative peak micturition pressure rel peak mic pressur (cm H2O) -∞ to ∞ None relaxation, maximal rate None   -∞ to ∞ None Resistin None (ng/ml) -∞ to ∞ None Respiratory Control RC   -∞ to ∞ Evaluation of Mitochondrial Function respiratory exchange ratio RQ   -∞ to ∞ None respiratory exchange ratio (Light Period) RER-L   0 to ∞ None reticulocytes Ret   0 to ∞ None Rg, adipose None (umol/100g/min) 0 to ∞ None Rg, brain None (umol/100g/min) 0 to ∞ None Rg, diaphragm None (umol/100g/min) 0 to ∞ None Rg, gastrocnemeous None (umol/100g/min) 0 to ∞ None Rg, heart None (umol/100g/min) 0 to ∞ None Rg, soleus None (umol/100g/min) 0 to ∞ None Rg, vastus lateralis None (umol/100g/min) 0 to ∞ None Right Coronary Artery Atherosclerosis Morphometry - Intimal Area RCAAM-IA (mm²) -∞ to ∞ Atherosclerotic Morphometry in Pigs Right Coronary Artery Atherosclerosis Morphometry - Intimal Area as % Medial Area RCAAM-IAMA (%) 0 to 100 Atherosclerotic Morphometry in Pigs Right Coronary Artery Atherosclerosis Morphometry - Medial Area RCAAM-MA (mm²) -∞ to ∞ Atherosclerotic Morphometry in Pigs Right Coronary Artery Atherosclerosis Morphometry - Percent Stenosis RCAAM-%S (%) 0 to 100 Atherosclerotic Morphometry in Pigs right kidney weight (mouse) R Kid Wt (g) 0 to ∞ Morphometry: Mouse RR systolic RR systolic (mmHg) 0 to ∞ None Sample Weight sample weight (mg) -∞ to ∞ None sciatic min f-lat None   0 to ∞ Nerve Conduction Velocity Tests sciatic motor amplitude sciatic motor amp   0 to ∞ Nerve Conduction Velocity Tests sciatic motor conduction velocity sciatic motor CV (m/s) 0 to ∞ Nerve Conduction Velocity Tests sciatic motor distal latency sciatic motor DL (msec) 0 to ∞ Nerve Conduction Velocity Tests serines None   0 to ∞ None serium insulin: 000min (baseline) S Insulin too (nmole) -∞ to ∞ None serium insulin: 030min (post injection) S Insulin t30 (nmole) -∞ to ∞ None serum albumin SAlb (g/dL) 0 to ∞ None serum albumin to globulin ratio A/G (ratio) 0 to ∞ None serum amylase S amylase (U/L) 0 to ∞ None serum calcium S calcium (mg/dL) 0 to ∞ None serum chloride Cl- (mEq/L) 0 to ∞ None serum creatine phosphokinase CPK (U/L) 0 to ∞ None serum gamma glutamyl transpeptidase GGTP (U/L) 0 to ∞ None serum globulin S Globulin (g/l) 0 to ∞ None serum glutamic pyruvic transaminase None   0 to ∞ None serum ICAM-1 concentration (ELISA) sICAM-1   0 to ∞ None serum lactic dehydrogenase lactic dehydrogenase   0 to ∞ None serum lipase S lipase (U/L) 0 to ∞ None serum magnesium S magnesium (mEq/L) 0 to ∞ None serum phosphorus S phosphorus (mg/dL) 0 to ∞ None serum potassium K (mEq/L) 0 to ∞ None serum sodium Na (mEq/L) 0 to ∞ None serum total bilirubin S total bilirubin (mg/dL) 0 to ∞ None serum total protein S Total Protein (g/dL) 0 to ∞ Serum, Blood and Body Weight Measurements in Pigs serum triglycerides TG (mg/dL) 0 to ∞ Lipid Profiles in Mice serum VCAM-1 concentration (ELISA) sVCAM-1   0 to ∞ None small myelinated fiber frequency small myf freq (%) 1 to 99 Preparing Nerves for Morphometry sodium, blood None   0 to ∞ None sphingomyelin None (µg/mg) 0 to ∞ None spleen weight Spleen Wt (g) 0 to ∞ Morphometry: Mouse spleen weight:tibia length ratio Spleen:TL (g/mm) 0 to ∞ Morphometry: Mouse spleen:body weight ratio Spleen:BW   0 to ∞ Morphometry: Mouse sterol synthesis None   -∞ to ∞ None sub-epidermal nerve plexi SNP (num/mm) 1 to 50 Prepare Plantar Footskin for Morphometry subcutaneous fat pad weight subFPW (g) 0 to ∞ None sural nerve conduction velocity sural NCV (m/s) 5 to 70 None tail compound muscle action potential tail CMAP   0 to ∞ None tail flick analgesia test TFAT (sec) 0 to ∞ Tail Flick tail motor amplitude tail motor amp   0 to ∞ Nerve Conduction Velocity Tests tail motor latency tail motor L (msec) 0 to ∞ Nerve Conduction Velocity Tests tail sensory amplitude TSA   0 to ∞ Nerve Conduction Velocity Tests tail sensory conduction velocity tail sensory CV (m/s) 5 to 70 Nerve Conduction Velocity Tests tail sensory nerve action potential tail SNAP   0 to ∞ Nerve Conduction Velocity Tests TAQ A   -∞ to ∞ None TCA cycle flux VTCA (µMol/min/g) -∞ to ∞ None temperature, body body temp (°C) 25 to 45 None Thiobarbituric Acid Reactive Substances TBARS (mmol/L) -∞ to ∞ None threonine None   0 to ∞ None tibia length (mouse) Tibia L (mm) 0 to ∞ Morphometry: Mouse Time to Peak Pressure None (10^3/mm3) -∞ to ∞ None total activity None   0 to ∞ None total albumin excretion total ualb (µg) 0 to ∞ None total aortic surface area TotAorticSA (mm²) 0 to ∞ Quantification of atherosclerosis at the aortic sinus total body weight None (g) -∞ to ∞ None total creatinine excretion total creat (mg) 0 to ∞ None total kidney weight (mouse) Tot Kid Wt (g) 0 to 3 Morphometry: Mouse total kidney:body weight ratio Kid:BW   0 to ∞ Morphometry: Mouse total length of epidermal:dermal border LengthED (mm) -∞ to ∞ None total lesion area on the aorta AorticLA (mm²) 0 to ∞ Quantification of atherosclerosis at the aortic sinus total mesangial cell volume Tot Mesangial CV (µm³) 0 to ∞ None total mesangial matrix volume Tot Mes Matrix Vol (µm³) 0 to ∞ None total mesangium volume Tot Mesangium Vol (µm³) 0 to ∞ None Total Radical-trapping Antioxidant Parameter TRAP   0 to ∞ TRAP triglyceride pool enrichment TG POOL   -∞ to ∞ None triglyceride remaining in intestinal lumen TG in IL (%) -∞ to ∞ None triglyceride remaining in intestinal mucosa TG in IM (%) -∞ to ∞ None triglyceride transported in lymph TG in Lymph (%) -∞ to ∞ None triglyceride, CM TG in CM (mg/dL) 0 to 10000 None triglyceride, fatty acids TGFA (%) 0 to 100 None triglyceride, fractional clearance rate TG FCR (min) -∞ to ∞ None triglyceride, HDL TG in HDL (mg/dL) -∞ to ∞ None triglyceride, hepatic uptake Hepatic TG uptake (% wt/wt) -∞ to ∞ None triglyceride, LDL TG in LDL (mg/dL) -∞ to ∞ None triglyceride, splenic uptake Splenic TG uptake (U/L) -∞ to ∞ None triglyceride, vLDL TG in VLDL (mg/dL) -∞ to ∞ None triglycerides TG (mg/dL) -∞ to ∞ None triglycerides in organ through extraction & determination None (U/L) -∞ to ∞ None triglycerides, tissue TG (tissue) (mg/g tissue) -∞ to ∞ None Tubulo-interstitial fibrosis Tubulo-interstitial fibrosis   -∞ to ∞ None tumor necrosis factor alpha concentration (ELISA) TNFa   0 to ∞ None tyrosines None   0 to ∞ None unesterified cholesterol None (µg/mg) 0 to ∞ None unesterified fatty acids None (µg/mg) 0 to ∞ None urea nitrogen, blood BUN (mg/dL) 0 to ∞ None urine albumin (Exocell Albulwell M ELISA) ualb (µg/ml) 0 to ∞ Urine Albumin ELISA (Albuwell M kit) urine albumin (spot) ualb-spot (µg/ml) 0 to ∞ Urine Albumin ELISA (Albuwell M kit) urine albumin/urine creatinine ratio ACR (µg/mg) 0 to ∞ Creatinine Companion Protocol Assay (Exocell) urine albumin/urine creatinine ratio (spot) ACR-spot (µg/mg) -∞ to ∞ Creatinine Companion Protocol Assay (Exocell) urine output urine output (ml) -∞ to ∞ None urine pH urine pH   0 to 14 None valine None   0 to ∞ None VCO2 30 Min Exercise None   0 to ∞ None VCO2 basal None   0 to ∞ None VCO2 exhaustion None   0 to ∞ None VCO2 max None   0 to ∞ None very-low density lipoprotein cholesterol VLDL (mg/dL) 0 to ∞ Ultracentrifugal separation of VLDL, LDL and HDL VO2 30 min exercise None   0 to ∞ None VO2 basal None   0 to ∞ None VO2 Exhaustion None   0 to ∞ None VO2 max None   0 to ∞ None VO2, maximum None   -∞ to ∞ None water intake water intake (ml/kg/hr) 0 to 4 None wet heart weight (mouse) W Hrt Wt (g) 0 to 3 Morphometry: Mouse wheel running day None   0 to ∞ None white blood cell count WBC (10^3/mm3) 0 to ∞ None Work Duration None (min) 0 to ∞ None WR max None   0 to ∞ None